E-LIB Suche - Ergebnisse für: Karadogan, I.

1

Nivolumab for relapsed or refractory Hodgkin lymphoma: Expe..:

Ferhanoglu, B. ; Bekoz, H. ; Karadurmus, N....
Hematological Oncology. 35 (2017) S2 - p. 321-323 , 2017

Link: https://doi.org/10.1002/..

2

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Salihoglu, A. ; Elverdi, T. ; Karadogan, I....
Annals of Hematology. 94 (2014) 3 - p. 415-420 , 2014

Link: https://doi.org/10.1007/..

3

Sheehan's syndrome associated with pancytopenia due to marr..:

Ozdogan, M. ; Yazicioglu, G. ; Karadogan, I....
International Journal of Clinical Practice. 58 (2004) 5 - p. 533-535 , 2004

Link: https://doi.org/10.1111/..

4

Irreversible renal failure in a patient with chronic lympho..:

Timuraĝaoĝlu, A. ; Karadoĝan, Ì. ; Ündar, L.
Annals of Hematology. 78 (1999) 2 - p. 109-110 , 1999

Link: https://doi.org/10.1007/..

5

39 Myelodysplastic syndrome and thrombotic thrombocytopenic..:

Ündar, L. ; Timurag˛aog˛lu, A. ; Karadog˛an, I.
Leukemia Research. 21 (1997) 1 - p. S10 , 1997

Link: https://doi.org/10.1016/..

6

NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPE..:

Ferhanoglu, B ; Bekoz, H ; Karadurmus, N...
Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı. , 2017

Link: https://hdl.handle.net/1..

7

Nivolumab for relapsed or refractory Hodgkin lymphoma: real..:

Bekoz, H ; Karadurmus, N ; Paydas, S...
10.1093/annonc/mdx341. , 2017

Link: https://hdl.handle.net/1..

8

NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPE..:

Bekoz, H ; Kaynar, L ; Karadogan, I...
Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı. , 2017

Link: https://hdl.handle.net/1..

9

Nivolumab For Relapsed Or Refractory Hodgkin Lymphoma: Real..:

Bekoz, H ; Karadurmus, N ; Paydas, S...
10.1093/annonc/mdx341. , 2017

Link: http://hdl.handle.net/11..

10

Nivolumab for relapsed or refractory Hodgkin lymphoma: real..:

Karadurmus, N ; Bekoz, H ; Paydas, S...
Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı. , 2017

Link: https://hdl.handle.net/1..

11

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Salihoglu A ; Elverdi T ; Karadogan I...
10.1007/s00277-014-2215-9. , 2015

Link: https://hdl.handle.net/2..

12

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Yegin, Z. A ; KARADURMUS, N ; SUCAK, G...
ddef9b56-56c2-414d-8f79-575567544c44. , 2015

Link: https://doi.org/10.1007/..

13

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Ferhanoglu, B ; Baslar, Z ; PAYDAŞ, SAİME...
ddef9b56-56c2-414d-8f79-575567544c44. , 2015

Link: https://doi.org/10.1007/..

14

Brentuximab Vedotin For Relapsed or Refractory Hodgkin Lymp..:

Salihoglu, A ; Elverdi, T ; Karadogan, I...
10.1007/s00277-014-2215-9. , 2015

Link: http://hdl.handle.net/11..

15

Brentuximab vedotin for relapsed or refractory Hodgkin lymp..:

Salihoglu, A ; Elverdi, T ; Karadogan, I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...